Liu Lin, Luo Pan, Yang Mingyi, Wang Jiachen, Hou Weikun, Xu Peng
Department of Joint Surgery, HongHui Hospital, Xi'an Jiaotong University, Xi'an, China.
Front Mol Biosci. 2022 Sep 20;9:1001212. doi: 10.3389/fmolb.2022.1001212. eCollection 2022.
Knee osteoarthritis (KOA) is one of the most common degenerative diseases, and its core feature is the degeneration and damage of articular cartilage. The cartilage degeneration of KOA is due to the destruction of dynamic balance caused by the activation of chondrocytes by various factors, with oxidative stress playing an important role in the pathogenesis of KOA. The overproduction of reactive oxygen species (ROS) is a result of oxidative stress, which is caused by a redox process that goes awry in the inherent antioxidant defence system of the human body. Superoxide dismutase (SOD) inside and outside chondrocytes plays a key role in regulating ROS in cartilage. Additionally, synovitis is a key factor in the development of KOA. In an inflammatory environment, hypoxia in synovial cells leads to mitochondrial damage, which leads to an increase in ROS levels, which further aggravates synovitis. In addition, oxidative stress significantly accelerates the telomere shortening and ageing of chondrocytes, while ageing promotes the development of KOA, damages the regulation of redox of mitochondria in cartilage, and stimulates ROS production to further aggravate KOA. At present, there are many drugs to regulate the level of ROS, but these drugs still need to be developed and verified in animal models of KOA. We discuss mainly how oxidative stress plays a part in the development of KOA. Although the current research has achieved some results, more research is needed.
膝骨关节炎(KOA)是最常见的退行性疾病之一,其核心特征是关节软骨的退变和损伤。KOA的软骨退变是由于多种因素激活软骨细胞导致动态平衡破坏,氧化应激在KOA发病机制中起重要作用。活性氧(ROS)的过度产生是氧化应激的结果,它是由人体固有抗氧化防御系统中出错的氧化还原过程引起的。软骨细胞内外的超氧化物歧化酶(SOD)在调节软骨中的ROS方面起关键作用。此外,滑膜炎是KOA发展的关键因素。在炎症环境中,滑膜细胞缺氧导致线粒体损伤,进而导致ROS水平升高,进一步加重滑膜炎。此外,氧化应激显著加速软骨细胞的端粒缩短和衰老,而衰老促进KOA的发展,损害软骨中线粒体氧化还原的调节,并刺激ROS产生以进一步加重KOA。目前,有许多调节ROS水平的药物,但这些药物仍需在KOA动物模型中进行开发和验证。我们主要讨论氧化应激如何在KOA的发展中起作用。尽管目前的研究已经取得了一些成果,但仍需要更多的研究。
Front Mol Biosci. 2022-9-20
Antioxidants (Basel). 2024-2-1
Int Immunopharmacol. 2023-10
MedComm (2020). 2025-8-1
Front Pharmacol. 2025-7-9
Front Cell Dev Biol. 2022-2-18
Evid Based Complement Alternat Med. 2021-12-8
Osteoarthritis Cartilage. 2021-11
J Bone Joint Surg Am. 2021-8-4